The Ministry of Health body that examines and registers medicines in Azerbaijan and keeps the state register. Cancer medicines, and medicines approved through the European centralised procedure, have shorter review times.
The Analytical Expertise Centre was created in 2007 on the initiative of the Ministry of Health to strengthen state control of the quality, efficacy and safety of medicines, and has operated as a public legal entity since 14 October 2019. It describes itself as an observer of the European and US pharmacopoeias and as working with WHO, the Global Fund and the Uppsala Monitoring Centre. Its state registration department registers and re-registers medicines, registers changes to dossiers, cancels registrations and keeps the state register. The coordinates are an approximate Baku city point.
The legal basis it cites is the Law on Medicines of 22 December 2006 (No. 208-IIIQ) and Cabinet of Ministers decision No. 345 of 18 July 2024 on the rules for state registration of medicines, medicinal substances and medical devices. Its page on review stages sets the initial review of a registration dossier at 15 working days and the specialised review at no more than 210 calendar days. For medicines authorised through the European Medicines Agency's centralised procedure the steps are 5 and 10 working days. For medicines on WHO's list of recommended products and those used to treat tuberculosis, HIV, infectious hepatitis, rare diseases and cancers they are 10 and 45 working days.
Azerbaijan's regulator does not appear on WHO's list of national regulatory authorities at maturity level 3 or 4 (August 2026).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/